Next Article in Journal
Characterizing the Clinical and Molecular Profile of SETD2-Mutated Lung Adenocarcinoma
Previous Article in Journal
CDK4/6 Inhibitors Plus Endocrine Therapy in Early-Stage HR+/HER2− Breast Cancer: Updated Meta-Analysis of Phase III Trials
 
 
Review

Article Versions Notes

Cancers 2025, 17(21), 3539; https://doi.org/10.3390/cancers17213539
Action Date Notes Link
article xml file uploaded 1 November 2025 07:19 CET Original file -
article xml uploaded. 1 November 2025 07:19 CET Update https://www.mdpi.com/2072-6694/17/21/3539/xml
article pdf uploaded. 1 November 2025 07:19 CET Version of Record https://www.mdpi.com/2072-6694/17/21/3539/pdf
article html file updated 1 November 2025 07:21 CET Original file https://www.mdpi.com/2072-6694/17/21/3539/html
Back to TopTop